CVRx Inc.

CVRX | NASDAQ

Price Alert Chart Builder DCF Calculator

$2.97

-$0.07 (-2.30%)

At close: Sep 21, 2026, 4:00 PM ET

$2.97

$0 (0.00%)

Pre-market: Sep 22, 2026, 4:00 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

-2.30%

(1D)

Rating

Updated: Aug 31, 2026

28.5

Fundamentals Weak

Market Sentiment Neutral

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $78.81M

1D Range

2.92 3.04

52W Range

2.20 11.30

Valuation (TTM)

PE -1.50

PB 3.95

EV/EBITDA -1.63

Valuation (NTM)

Forward PE N/A

Forward PEG 0.38

Price Target $4.13

Cash Flow

FCF Yield -67.7%

SBC Adj. FCF Yield -86.9%

SBC Impact -28.5%

Margins

Gross Margin 86.6%

Operating Margin -79.5%

FCF Margin -87.2%

Growth (CAGR)

Revenue 3Y | 5Y 25.6% | 46.5%

Dil EPS 3Y | 5Y 13.1% | -1.2%

FCF 3Y | 5Y -17.4% | -5.7%

Returns

ROA -56.3%

ROE -152.3%

ROIC -59.6%

Financial Health

Net Cash

$5.57M

Current Ratio 8.04

Interest Coverage -8.07

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

CVRx, Inc. is a commercial-stage medical technology company focused on innovating, producing, and bringing to market neuromodulation solutions designed for individuals battling cardiovascular diseases...

Sector Healthcare

Industry Medical - Devices

Employees 223

IPO Date Jun 29, 2021

Website www.barostim.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.

Earnings

Next Earnings

Nov 4, 2026

EPS Est

Pro

Rev Est

Pro

Earnings Details ➞

Analyst Summary

# of Analysts

Consensus

Buy

Price Target

Upside

+34.68%

Buy (2)

Hold (1)

Sell (0)

Analyst Details ➞